Clinical outcomes of pulsatile and non-pulsatile mode of perfusion

Journal of Extra-Corporeal Technology

Volumn 41, Issue 1, 2009, Pages

  Haines, Nikkole ^a   Wang, Shigang ^a   Ündar, Akif ^b   Alkan, Tijen ^c   Akcevin, Atif ^c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE CHILDREN S HOSPITAL   (United States)

^c AMERICAN HOSPITAL   (Turkey)

Author keywords

Cardiopulmonary bypass; Non pulsatile perfusion; Pulsatile perfusion; Surplus hemodynamic energy

Indexed keywords

CYTOKINE; DOBUTAMINE; DOPAMINE; ENDOTHELIN; ENDOTHELIN 1; HORMONE; INOTROPIC AGENT; INTERLEUKIN 8;

BLOOD LEVEL; CARDIOPULMONARY BYPASS; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; HEART; HEART PERFUSION; HOSPITALIZATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTENSIVE CARE UNIT; INTUBATION; KIDNEY; LUNG; PILOT STUDY; PULSATILE FLOW; URINE VOLUME; HEMODYNAMICS; INSTRUMENTATION; METHODOLOGY; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

CARDIOPULMONARY BYPASS; HEMODYNAMICS; HUMANS; PULSATILE FLOW; RISK FACTORS; TREATMENT OUTCOME;

EID: 68549087099     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Ji B, Ündar A. An evaluation of the benefits of pulsatile versus non-pulsatile perfusion during CPB in pediatric and adult cardiac patients. ASAIO J. 2006;52:357-61.
2. Ündar A. Principles and practices of pulsatile perfusion in pediatric and adult open-heart surgery. Türk Göǧüs Kalp Damar Cer Derg. 2004;12:215-9.
3. Shepard R, Simpson D, Sharp J. Energy equivalent pressure. Arch Surg. 1996;93:730-40.
4. Ündar A, Koenig K, Frazier O, Fraser C. Impact of membrane oxygenators on pulsatile versus nonpulsatile perfusion in a neonatal model. Perfusion. 2003;18:135-6.
5. Koster A, Merkle F, Hansen R, et al. Elimination of recombinant hirudin by modified ultrafiltraiton during simulated cardiopulmonary bypass: Assessment of different filter systems. Anesth Analg. 2000;91:265-9.
6. Ündar A, Ji B, Lukic B, et al. Quantification of perfusion modes in terms of surplus hemodynamic energy levels in a simulated pediatric CPB model. ASAIO J. 2006;52:712-7.
7. Rider A, Ji B, Kunselman A, Weiss W, Myers J, Undar A. A Performance evaluation of eight geometrically different 10 Fr pediatric arterial cannulae under pulsatile and nonpulsatile perfusion conditions in an infant cardiopulmonary bypass model. ASAIO J. 2008;54:306-15.
8. Ündar A, Lodge A, Runge T, Daggett C, Ungerleider R, Calhoon J. Design and performance of a physiologic pulsatile flow neonate-infant cardiopulmonary bypass system. ASAIO J. 1996;42:M580-3.
9. Ündar A, Lodge A, Daggett C, Runge T, Ungerleider R, Calhoon J. The type of aortic cannula and membrane oxygenators affect the pulsatile waveform morphology produced by a neonate-infant cardiopulmonary bypass system in vivo. Artif Organs. 1998;22:681-6.
10. Ündar A, Eichstaedt H, Masai T, et al. Comparison of six pediatric cardiopulmonary bypass pumps during pulsatile and nonpulsatile perfusion. J Thorac Cardiovasc Surg. 2001;122:827-9.
11. Ündar A. Pulsatiile versus nonpulsatile cardiopulmonary bypass procedures in neonates and infants: From bench to clinical practice. ASAIO J. 2005;51:vi-x.
12. Nakamura K, Harasaki H, Fukumura F, Fukamachi K, Whalen R. Comparison of pulsatile and non-pulsatile cardiopulmonary bypass or regional renal blood flow in sheep. Scand Cardiovasc J. 2004;38:000-005.
13. Herreros J, Berjano E, Sola J, et al. Injury in organs after cardiopulmonary bypass: A comparative experimental morphological study between a centrifugal and a new pulsatile pump. Artif Organs. 2004;28:738-42.
14. Gu U, de Kroon T, Elstrodt J, Rakhorst G. Gastrointestinal motility during cardiopulmonary bypass: A sonomicormetric study. Artif Organs. 2006;30:548-53.
15. Lynch J, Pouch A, Sanders R, Hinders M, Rudd K, Sevick J. Gaseous microemboli sizing in extracorporeal circuits using ultrasound backscatter. Ultrasound Med Biol. 2007;33:1661-75.
16. Schreiner R, Rider A, Myers J, et al. Microemboli detection and classification by innovative ultrasound technology during simulated neonatal cardiopulmonary bypass at different flow rates, perfusion modes, and perfusate temperatures. ASAIO J. 2008;54:316-24.
17. Alkan T, Akçevin A, Ündar A, Türkoǧlu H, Paker T, Aytaç A. Effects of pulsatile and nonpulsatile perfusion on vital organ recover in pediatric heart surgery: A pilot clinical study. ASAIO J. 2006;52:530-5.
18. Alkan T, Akçevin A, Ündar A, Türkoǧlu H, Paker T, Aytaç A. Benefits of pulsatile perfusion on vital organ recovery during and after pediatric open heart surgery. ASAIO J. 2007;53:651-4.
19. Alkan-Bozkaya T, Akçevin A, Ündar A, Türkoǧlu H, Paker T, Aytaç A. Pulsatile perfusion on vital organ recovery during and after pediatric open-heart surgery in ventricular septal defects. Proceedings of the Fourth International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Perfusion, May 21-24, 2008, Portland, OR.
20. Alkan-Bozkaya T, Akçevin A, Ündar A, Türkoǧlu H, Aytaç A. Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass: is there a difference between the pulsatile and nonpulsatile perfusion modes? Proceedings of the Fourth International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Perfusion, May 21-24, 2008, Portland, OR.
21. Orime Y, Shiono M, Hata H, et al. Cytokine and endothelial damage in pulsatile and nonpulsatile cardiopulmonary bypass. Artif Organs. 1999;23:508-12.
22. Sezai A, Shiono M, Nakata K, et al. Effects of pulsatile CPB on interleukin-8 and endothelin-1 levels. Artif Organs. 2005;29:708-13.
23. Ji B, Ündar A. Comparison of perfusion modes on microcirculation during acute and chronic cardiac support: Is there are difference? Perfusion. 2007;22:115-9.